Art. 45 Regulation (EU) 2017/745

Review of notified body assessment of technical documentation and clinical evaluation documentation

In forcesince 5 Apr 2017cited 2×
1.

The authority responsible for notified bodies, as part of its ongoing monitoring of notified bodies, shall review an appropriate number of notified body assessments of manufacturers' technical documentation, in particular the clinical evaluation documentation as referred to in points (c) and (d) of Section 6.1 of Annex II to verify the conclusions drawn by the notified body based on the information presented by the manufacturer. The reviews by the authority responsible for notified bodies shall be conducted both off-site and on-site.

2.

The sampling of files to be reviewed in accordance with paragraph 1 shall be planned and representative of the types and risk of devices certified by the notified body, in particular high-risk devices, and be appropriately justified and documented in a sampling plan, which shall be made available by the authority responsible for notified bodies to the MDCG upon request.

3.

The authority responsible for notified bodies shall review whether the assessment by the notified body was conducted appropriately and shall check the procedures used, associated documentation and the conclusions drawn by the notified body. Such checking shall include the technical documentation and clinical evaluation documentation of the manufacturer upon which the notified body has based its assessment. Such reviews shall be conducted utilising CS.

4.

Those reviews shall also form part of the re-assessment of notified bodies in accordance with Article 44(10) and the joint assessment activities referred to in Article 47(3). The reviews shall be conducted utilising appropriate expertise.

5.

Based on the reports of the reviews and assessments by the authority responsible for notified bodies or joint assessment teams, on input from the market surveillance, vigilance and post-market surveillance activities described in Chapter VII, on the continuous monitoring of technical progress, or on the identification of concerns and emerging issues concerning the safety and performance of devices, the MDCG may recommend that the sampling, carried out under this Article, cover a greater or lesser proportion of the technical documentation and clinical evaluation documentation assessed by a notified body.

6.

The Commission may, by means of implementing acts, adopt measures setting out the detailed arrangements, associated documents for, and coordination of, the review of assessments of technical documentation and clinical evaluation documentation, as referred to in this Article. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 114(3).

  • Order of the General Court (Sixth Chamber) of 23 May 2023. Atesos medical AG and Others v European Commission.Decision

    Articles 35 to 50 of Regulation 2017/745 relating to notified bodies are therefore applicable to the applicants’ situation.

    23 May 2023 · 62021TO0764(01)

  • Order of the Court (Seventh Chamber) of 11 April 2024. Atesos medical AG and Others v European Commission and Others.Decision

    In the second place, in paragraphs 40 and 41 of the order under appeal, the General Court held that Articles 35 to 50 of Regulation 2017/745 are applicable to the appellants’ situation.

    11 Apr 2024 · 62023CO0491